ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: MolecularMD is a manufacturer of molecular diagnostic tests for oncology applications, including a qRT-PCR assay to measure BCR-ABL levels prior to initiation of chronic myeloid leukemia (CML) therapy.